We first assessed the mRNA expression of KLK6, and the other members of the PDAC-specific KLK cluster, in widely used human PDAC cell lines and colon cancer cells as KLK-expressing controls [10,25] (Figure S3). The gene discussed is KLK6; the disease is malignant colon neoplasm.